Knowledge, Attitudes, and Acceptance of COVID-19 Vaccines among Secondary School Pupils in Zambia: Implications for Future Educational and Sensitisation Programmes.
COVID-19 vaccines
Zambia
adolescents
attitude
children
hesitancy
knowledge
pupils
secondary schools
vaccine acceptance
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
14 Dec 2022
14 Dec 2022
Historique:
received:
24
11
2022
revised:
07
12
2022
accepted:
09
12
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic resulted in the closure of schools to slow the spread of the virus across populations, and the administration of vaccines to protect people from severe disease, including school children and adolescents. In Zambia, there is currently little information on the acceptance of COVID-19 vaccines among school-going children and adolescents despite their inclusion in the vaccination programme. This study assessed the knowledge, attitudes, and acceptance of COVID-19 vaccines among secondary school pupils in Lusaka, Zambia. A cross-sectional study was conducted from August 2022 to October 2022. Of the 998 participants, 646 (64.7%) were female, and 127 (12.7%) would accept to be vaccinated. Those who were willing to be vaccinated had better knowledge (68.5% vs. 56.3%) and a positive attitude (79.1% vs. 33.7%) compared to those who were hesitant. Overall, the odds of vaccine acceptance were higher among pupils who had higher knowledge scores (AOR = 11.75, 95% CI: 6.51-21.2), positive attitude scores (AOR = 9.85, 95% CI: 4.35-22.2), and those who knew a friend or relative who had died from COVID-19 (AOR = 3.27, 95% CI: 2.14-5.09). The low vaccine acceptance among pupils is of public health concern, emphasising the need for heightened sensitisation programmes that promote vaccine acceptance among pupils in Zambia.
Identifiants
pubmed: 36560551
pii: vaccines10122141
doi: 10.3390/vaccines10122141
pmc: PMC9784903
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
BMC Public Health. 2021 Sep 26;21(1):1759
pubmed: 34565351
PLoS One. 2022 May 23;17(5):e0268084
pubmed: 35604938
Front Public Health. 2022 Feb 08;10:796467
pubmed: 35211440
Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Int Braz J Urol. 2020 Jul;46(suppl.1):120-124
pubmed: 32550706
Int J Environ Res Public Health. 2021 Mar 01;18(5):
pubmed: 33804558
J Infect Public Health. 2022 Feb;15(2):228-240
pubmed: 35042059
Euro Surveill. 2021 May;26(21):
pubmed: 34047271
PLoS One. 2022 May 18;17(5):e0268711
pubmed: 35584110
Expert Rev Vaccines. 2021 Aug;20(8):921-933
pubmed: 34252336
NASN Sch Nurse. 2021 May;36(3):156-163
pubmed: 33618566
Glob Health Res Policy. 2022 Jul 19;7(1):21
pubmed: 35850783
Vaccines (Basel). 2022 Oct 12;10(10):
pubmed: 36298567
Lancet Glob Health. 2020 Oct;8(10):e1264-e1272
pubmed: 32687792
PLoS One. 2022 Jul 11;17(7):e0271305
pubmed: 35816505
Int J Infect Dis. 2021 Jan;102:455-459
pubmed: 33035675
Pan Afr Med J. 2020 Oct 08;37:136
pubmed: 33425169
Arch Public Health. 2021 Aug 21;79(1):150
pubmed: 34419145
Child Youth Serv Rev. 2021 Aug;127:106065
pubmed: 34728871
Cochrane Database Syst Rev. 2020 Sep 15;9:CD013574
pubmed: 33959956
Int J Environ Res Public Health. 2022 Jan 07;19(2):
pubmed: 35055476
PLoS One. 2022 Jan 21;17(1):e0260733
pubmed: 35061702
PLoS One. 2022 Apr 7;17(4):e0266670
pubmed: 35390097
Front Microbiol. 2020 Jul 14;11:1526
pubmed: 32760367
Vaccine. 2012 Aug 3;30(36):5363-7
pubmed: 22732428
Front Pharmacol. 2022 Aug 19;13:926507
pubmed: 36059994
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6
pubmed: 34227914
Infect Drug Resist. 2021 Jun 01;14:2015-2025
pubmed: 34103948
Lancet Infect Dis. 2022 Jan;22(1):43-55
pubmed: 34480857
Front Med (Lausanne). 2022 May 19;9:820544
pubmed: 35665358
Front Psychol. 2022 Jun 10;13:900386
pubmed: 35756213
Health Serv Res Manag Epidemiol. 2022 Jun 13;9:23333928221106269
pubmed: 35720257
J Med Virol. 2021 Dec;93(12):6535-6543
pubmed: 34255346
BMJ. 2021 Nov 17;375:e068302
pubmed: 34789505
J Med Virol. 2022 Jan;94(1):253-262
pubmed: 34463956
BMJ. 2022 May 18;377:e069676
pubmed: 35584816
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccine. 2022 Feb 11;40(7):967-969
pubmed: 35063284
BMJ Open. 2021 Apr 24;11(4):e050189
pubmed: 33895723
Appl Health Econ Health Policy. 2020 Jun;18(3):325-328
pubmed: 32249362
Vaccines (Basel). 2022 Jul 27;10(8):
pubmed: 35893839
Hum Cell. 2021 May;34(3):711-733
pubmed: 33677814
Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307
pubmed: 35509962
Int J MCH AIDS. 2020;9(3):381-385
pubmed: 33014624
Vaccine. 2022 Mar 18;40(13):2028-2035
pubmed: 35181151
Vaccine. 2021 Jun 11;39(26):3473-3479
pubmed: 34023134
J Adolesc Health. 2022 Aug;71(2):164-171
pubmed: 35718652
Hum Vaccin Immunother. 2022 Dec 31;18(1):2027160
pubmed: 35113777
Fam Med Community Health. 2022 Apr;10(2):
pubmed: 35470223
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138
pubmed: 35085223
Vaccines (Basel). 2021 Feb 19;9(2):
pubmed: 33669659
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):997-1003
pubmed: 34264908
Vaccine. 2022 Mar 18;40(13):2114-2121
pubmed: 35153088
Molecules. 2020 Dec 23;26(1):
pubmed: 33374759
Int J Environ Res Public Health. 2021 Mar 27;18(7):
pubmed: 33801651
Clin Exp Immunol. 2020 Nov;202(2):162-192
pubmed: 32935331
Vaccines (Basel). 2021 May 17;9(5):
pubmed: 34067682
Vaccines (Basel). 2022 Sep 17;10(9):
pubmed: 36146631
Vaccines (Basel). 2022 May 11;10(5):
pubmed: 35632513
Chronic Illn. 2023 Jun;19(2):279-303
pubmed: 35404175
Lancet Glob Health. 2022 Aug;10(8):e1090-e1091
pubmed: 35691328
Health Serv Res Manag Epidemiol. 2022 May 3;9:23333928221098903
pubmed: 35528024
BMC Public Health. 2022 Feb 4;22(1):226
pubmed: 35114965
EClinicalMedicine. 2021 Oct;40:101144
pubmed: 34608453
J Korean Med Sci. 2021 Aug 09;36(31):e227
pubmed: 34402237
BMJ Open. 2021 Dec 15;11(12):e055159
pubmed: 34911723
BMJ. 2021 Sep 16;374:n2282
pubmed: 34531181
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Front Public Health. 2021 Nov 05;9:736976
pubmed: 34805065
Vaccine. 2022 Mar 15;40(12):1846-1854
pubmed: 35153096
Vaccines (Basel). 2022 Mar 15;10(3):
pubmed: 35335083
J Med Virol. 2022 May;94(5):1766-1767
pubmed: 34936106
Commun Med (Lond). 2022 Sep 12;2:113
pubmed: 36101704
NPJ Vaccines. 2022 Feb 10;7(1):20
pubmed: 35145102
BMC Public Health. 2022 Jan 18;22(1):128
pubmed: 35042476
Hum Vaccin Immunother. 2021 Sep 2;17(9):2962-2964
pubmed: 33890838
Pan Afr Med J. 2022 Feb 08;41:112
pubmed: 35465376
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Procedia Vaccinol. 2011;5:127-136
pubmed: 32288915
BMC Med. 2022 May 23;20(1):200
pubmed: 35606843
Ther Adv Vaccines Immunother. 2022 Mar 24;10:25151355221088159
pubmed: 35355936
Vaccine X. 2021 Dec;9:100117
pubmed: 34693273
Sci Transl Med. 2022 May 4;14(643):eabm3410
pubmed: 35315683
Syst Rev. 2022 Apr 26;11(1):78
pubmed: 35473819
Int Rev Immunol. 2022 May 28;:1-22
pubmed: 35635216
BMC Public Health. 2021 May 29;21(1):1015
pubmed: 34051769
EClinicalMedicine. 2021 Oct;40:101113
pubmed: 34490416
Vaccines (Basel). 2021 Aug 23;9(8):
pubmed: 34452061
PLoS One. 2022 Jul 15;17(7):e0270485
pubmed: 35839210
Nat Microbiol. 2022 May;7(5):716-725
pubmed: 35477751
Pan Afr Med J. 2021 Sep 03;40:10
pubmed: 34650660
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
Patient Prefer Adherence. 2022 Apr 24;16:1093-1103
pubmed: 35492852
Vaccines (Basel). 2022 Sep 22;10(10):
pubmed: 36298459
Healthcare (Basel). 2021 Dec 13;9(12):
pubmed: 34946448
J Med Internet Res. 2020 Aug 19;22(8):e19996
pubmed: 32750004
Antibiotics (Basel). 2022 Mar 25;11(4):
pubmed: 35453198
Nature. 2020 Oct;586(7827):113-119
pubmed: 32707573
Eur J Med Chem. 2022 Oct 5;240:114570
pubmed: 35779291